Schedule 13G ownership disclosure
FIVE PRIME THERAPEUTICS INC
Security class unavailable · CUSIP: 33830X104
Event date: 2019-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-19-002694
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Nov 08, 2019
- Reporting period
- Nov 06, 2019
- Description
- Schedule 13G beneficial ownership